From Corporate Engineer to Medtech CEO: The Brutal Truth About Startups with Nathan Friedman

Nathan Friedman spent two decades at medical giant W.L. Gore before walking away to solve a problem that affects one in ten femoral access procedures: visual inspections to find internal bleeding often miss the issue until a patient loses nearly a liter of blood. Nathan founded HemaSense to replace this manual method with a wearable patch that detects subcutaneous bleeding in real-time through impedance changes.Moving from corporate engineer to startup CEO required Nathan to build a new skill set from scratch, starting with a basic search on how investment structures work. He details how he validated the clinical need by talking directly to physicians and identified the $18,000 cost savings that convinces hospitals to adopt new technology.⚠️ FOUNDER CONFESSION [10:42]:"I came back to my room that night... and one of the first questions I plugged in there was 'What is the difference between private equity and venture capital and angel investors?' Because I was like, ‘What is this? I don't even know what these terms mean.’"Watch as Nathan explains how he systematically filled his knowledge gaps to secure funding and build a viable business model.📊 COST ANALYSIS BREAKDOWN [21:21]:"When one of these bleeding complications occurs, it's an average of two extra days in the hospital. And the latest data that we have is that it's about $18,000 in direct cost to the hospital when these patients stay that long."See exactly how HemaSense targets a specific economic driver to align patient safety with hospital profitability.✅ VALIDATION BLUEPRINT [28:04]:"We want to make sure that we don't just have that feedback cycle once, but we are having that feedback cycle continuously through our development... We pick up the phone or we go drive down to the place that we have these partnerships set up and we ask the people who are going to be using it."Nathan details why continuous clinical validation beats building in isolation every time.CHAPTERS:00:00 - Introducing Nathan Friedman and His Path to MedTech Innovation01:35 - From Gore to Entrepreneurship and Building Startup Mindset04:54 - Making the Leap to Founding HemaSense07:53 - How HemaSense Formed and the Problem It Set Out to Solve10:13 - Learning Funding Strategy and Navigating Investor Expectations13:12 - Closing the Pre-Seed Round and Early Technical Milestones14:44 - How the HemaSense Wearable Patch Detects Subcutaneous Bleeding17:46 - Real-Time Monitoring, Alerts, and Clinical Workflow Integration19:28 - Current Standard of Care Limitations and Hospital Cost Burdens23:08 - Expanding Into Ambulatory and At-Home Monitoring Applications27:00 - Building Strategic Clinical Partnerships for Product Validation30:36 - What Keeps a Startup CEO Up at Night34:16 - Key Lessons for Founders Entering MedTech Innovation🔗 CONNECT WITH NATHAN:• LinkedIn: https://www.linkedin.com/in/nathanfriedman/• HemaSense: https://www.hemasense.com/#MedTech #StartupFounder #HealthcareInnovation